loader2
Partner With Us NRI

Abbott India Ltd share Price Today

Company details

26,107.55
26,499.95
20,605.05
29,638.95
6M Return 17.54%
1Y Return 15.79%
Mkt Cap.(Cr) 55,714.35
Volume 22,533
Div Yield 1.23%
OI
-
OI Chg %
-
Volume 22,533

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Power brands continue to drive growth…
About The Stock

    Abbott India is one of the fastest growing listed MNC pharma companies. It has outperformed the industry on a consistent basis in women’s health, GI, metabolic, pain, CNS among others.

    • Some of the top brands- Thyronorm, Udiliv, Duphalac, Duphaston, Cremafin Plus and Veritn have been the growth drivers besides new launches
    • Abbott has 140+ brands in segments of women’s health, gastroenterology, metabolics, CNS, multi-specialty, vaccines & consumer health
Q3FY23 Results

    Abbott India’s numbers were broadly in line with our estimates.

    • Revenues increased 8.3% YoY to ₹ 1326.5 crore
    • EBITDA grew 17.6% YoY to ₹ 316.5 crore while EBITDA margins increased 188 bps to 23.9%
    • PAT increased 23.9 % YoY to ~₹ 247 crore

Click here for full recommendation

Research view on more stocks

Abbott India Ltd shares SWOT Analysis

Strengths (10)

  • Company with high TTM EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Weakness (1)

  • Decline in Net Profit (QoQ)

Opportunity (0)

Data not found

Threats (5)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Red Flag: Resignation of Top Management

Resistance and support

R1 26,444.0
R2 26,668.2
R3 26,836.4
Pivot

26,275.75

S1 26,051.6
S2 25,883.4
S3 25,659.2
EMA SMA
26,995.9
27,018.6
26,191.3
24,855.4
27,192.0
27,840.9
25,878.3
24,526.9
Delivery and volume
Name Category Shares
ABBOTT CAPITAL INDIA LIMITED PROMOTER 50.44%
ABBOTT HEALTHCARE PRODUCTS LIMITED PROMOTER 17.62%
BRITISH COLLOIDS LIMITED PROMOTER 6.92%

OUR RESEARCH VIEW

Investment recommendation
Power brands continue to drive growth…
Call Date
13 Feb 2023
Entry Price 20,135.00
Target Price 21,025.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Abbott India Ltd Stocks COMPARISON

Financials( in Cr) Abbott India Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 26,219.75 1,540.05 1,381.40 6,010.85 3,716.55
% Change -0.85 0 -1.10 -1.20 -1.67
Mcap Cr 55,714.35 369,509.59 111,527.33 100,266.39 98,662.88
Revenue TTM Cr 5,379.08 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 949.41 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 49.09 39.38 28.51 19.41 72.54
1 Year Return 15.79 51.48 50.49 23.15 15.70
ROCE 39.94 16.79 14.76 25.99 19.30
ROE 31.60 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 3,188.54 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,701.14 -977.22
LAST 3M 84,025.63 45,820.51
LAST 6M 131,642.99 78,083.44
LAST 12M 206,655.58 204,047.57
Abbott India appoints Commercial Director - Women`s Health, Metabolics and International Business

Apr 12, 2024 l BSE Announcement

Date Action Type Ratio
Jul 21, 2023 Dividend 1800
Jul 21, 2023 Dividend 1450
Aug 02, 2022 Dividend 1450

Abbott India Ltd Information

Stock PE (TTM)
49.09
Promoter Holding
74.99%
Book Value
1463.0212
ROCE
39.94%
ROE
31.6%
Description
  • Abbott India Limited is a pharmaceutical company and has a market capitalization of Rs. 40,158.27 crores as of 25th August 2021. The company has reported its revenue income from operations of Rs. 4,310 crores at the end of March 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 500488 and scrip code ABBOTINDIA. As of 25th August 2021, Abbott India Limited was trading at Rs. 18,898.90.

    Abbott India Limited was a subsidiary of Abbott Laboratories, USA. Since 1944 they are working for the advancement of healthcare in India. It was incorporated on 22nd August '1944 as Boots Pure Drug Company (India) Ltd. In July '2002, they have changed their name to Abbott India Ltd. The company features a headquarters in north suburban Chicago; they serve in additional than 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. The company has 3,585 permanent employees on the roll. The Promoter & Promoter group holding in the company has remained constant since the last year, i.e., 74.99%. The Balance of 25.01% is by others which involve Mutual Funds (3.42%), Venture Capital Funds (0.13%), foreign portfolio investors (0.25%), Financial Institutions/Banks (0.42%), Insurance Companies (1.96%), and non-Institutions (18.03%).

    In June 2021, the company has a profit of Rs. 195.76 crores, which had increased by 7.87% from Rs. 180.35 crores in the quarter ending June’20. From Rs. 279.04 crores in March 2020, Abbott India Limited EPS has risen to Rs. 325.04 crores in March 2021. EBIDTA margin has also increased by 23.3% in 2021 (Rs. 1,002 crores) compared to 2020 (Rs. 871 crores). Abbott India Limited stock closed at Rs. 18,806.75 on 23rd August '2021 (NSE) and has a return of 25.77% in the last six months (On 23rd March 2021 stock market price Rs. 13,959.80) and 35.36% in the previous year. Book value per share has increased to 1,225 in FY 2020-21 from 1,144 in FY 2019-20. The interest coverage ratio has been decreased to 51.7 times in FY 2020-21 from 95.1 times in FY 2019-20 due to the accounting impact of IND AS 116 –Lease.

Registered Address

Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Tel : 91-22-67978888/50461000/2000/1119
Email : investorrelations.india:abbott.com; webmaster:abbo
Website : http://www.abbott.co.in
Registrar

Sharepro Services India P Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500488
NSE Code : ABBOTINDIA
Book Closure Date (Month) :
BSE Group : A
ISIN : INE358A01014

FAQ’s on Abbott India Ltd Shares

You can buy Abbott India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Abbott India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 15, 2024 03:50 PM the closing price of Abbott India Ltd was ₹ 26,219.75.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 15, 2024 03:50 PM, the market cap of Abbott India Ltd stood at ₹ 55,714.35.

The latest PE ratio of Abbott India Ltd as of Apr 15, 2024 03:50 PM is 49.09

The latest PB ratio of Abbott India Ltd as of Apr 15, 2024 03:50 PM is 0.06

The 52-week high of Abbott India Ltd share price is ₹ 29,638.95 while the 52-week low is ₹ 20,605.05

According to analyst recommendations, Abbott India Ltd Share has a “Buy” rating for the long term.

Download Our

Download App
market app